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This study aims to investigate the relation between vaginal microbiota and exposition to intra-amniotic 
inflammation (IAI). We conducted a prospective cohort study in women with preterm labor <34 weeks 
who had undergone amniocentesis to rule out IAI. Vaginal samples were collected after amniocentesis. 
Women with IAI included those with positive amniotic fluid (AF) for a microorganism identified by 
specific culture media and Sanger sequencing 16S ribosomal RNA gene and/or high AF interleukin 
(IL)-6 levels. Vaginal microbiota was characterized by 16S ribosomal RNA gene amplicon sequencing. 
Specific quantitative PCR targeted to Lactobacillus spp. was also performed. Regression models 
were used to evaluate associations between vaginal microbiota and exposition to IAI. Concerning our 
results, 64 women were included. We observed an inverse association between AF IL-6 levels and load 
of Lactobacillus spp. Depletion in Lactobacillus spp. load was significantly associated with an early 
gestational age at delivery and a short latency to delivery. Microbial-diversity was found to be a risk 
factor for the subsequent occurrence of clinical chorioamnionitis. To the contrary, higher Lactobacillus 
spp. load had a protective role. In conclusion, the study identifies reduced bacterial load of Lactobacillus 
spp. in women exposed to IAI and found microbial-diversity and Lactobacillus spp. depletion to be 
associated with a worse perinatal outcome.
The effects of prematurity on infants, parents and society make preterm birth an important issue in public health 
worldwide1. The time of presentation of symptoms is important in the pathophysiology of preterm labor (PTL)2,3. 
Therefore, the earliest spontaneous preterm births (sPTB)4 are most likely considered related to intra-amniotic 
inflammation (IAI).
IAI can develop through microbial invasion of the amniotic cavity (MIAC) or through other mechanisms 
related to endogenous mediators from the placenta and fetal membranes that trigger IAI similarly to MIAC but 
leading to “sterile” IAI5.
The use of next-generation sequencing techniques has been instrumental to describe and characterize the 
healthy human vaginal environment. The depletion of Lactobacillus spp. has been related to a poor reproductive6 
and infectious outcome7–10.
Little is known on the relation between vaginal microbiota composition and exposition to IAI in women with 
PTL. Concerning this, Hitti et al.11 did observe a high expression of vaginal cytokines, an abnormal vaginal Gram 
stain, absence of hydrogen peroxide-producing Lactobacillus and the presence of anaerobic vaginal flora in the 
vaginal cultures of women with MIAC and IAI. However, this standard microbiological method of diagnosis only 
identifies a small part of the multitude of microorganisms, many of which are very difficult to cultivate, or are 
considered non-cultivable.
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In this scenario, the main aim of this study was to evaluate the relation between vaginal microbiota and expo-
sition to IAI in women with PTL determined by 16S ribosomal RNA gene amplicon sequencing and specific 
quantitative PCR targeted to Lactobacillus spp. We also aimed to investigate the association between vaginal 
microbiota and gestational age at delivery and other infectious/inflammatory outcomes.
Results
Baseline characteristics of the study population. Sixty-nine women were included. Maternal charac-
teristics and pregnancy management are summarized in Table 1. Data of delivery was missing in 5 women with 
No-MIAC/Non-IAI.
Two vaginal samples were excluded from the analyses due to the low number of reads obtained and three due 
to the presence of high levels of Burkholderia cepacia, considered external contaminant bacteria.
The final sub-set (n = 64) included 14 women with MIAC.
The most common microorganism identified in the amniotic fluid was Ureaplasma spp. (n = 5). Others were 
Mycoplasma hominis (n = 1), Mycoplasma hominis and Fusobacterium nucleatum (n = 1), Sneathia sanguinegens 
and Prevotella amnii (n = 1), Streptococcus agalactiae (n = 1), Streptococcus lutetiensis (n = 1), Capnocytophaga 
sputigena (n = 1), Candida albicans (n = 1), Roseomonas mucosa (n = 1), Rhodococcus spp. (n = 1). The only 
microorganisms identified by Sanger sequencing 16S ribosomal RNA but not by culture were Roseomonas 
mucosa and Rhodococcus spp. Both presented high levels of amniotic fluid IL-6. The other microorganisms were 
identified by culture and confirmed by Sanger sequencing of the 16S ribosomal RNA gene.
Alpha and Beta-diversity of the vaginal microbiota in women with IAI. Women with IAI had 
higher microbial-diversity (p = 0.008, Shannon index) but not higher richness than the No-MIAC/Non-IAI group 
(Fig. 1A).
Beta-diversity analysis of microbial communities using both weighted and unweighted UNIFRAC and, also, 
Bray Curtis distance did not show differences in clustering by IAI (Supplemental data S1).
IAI (n = 21) No-MIAC/Non-IAI (n = 43) p
Maternal age (y) 32.0 (26.8; 36.4) 33.2 (28.8; 38.3) 0.548
Body Mass Index (kg/m2) 22.2 (20.5; 25.8) 22.3 (20.9; 25.5) 0.966
Ethnicity 0.287
-Caucasian 13 (62) 31 (72)
-Afro-Caribbean 2 (10) 1 (2)
-Arabian 5 (24) 7 (16)
-Black 0 2 (5)
-Asian 1 (5) 0
-Other 0 2 (5)
Nulliparity 14 (67) 23 (53) 0.316
Smoking 3 (14) 3 (7) 0.346
Diabetes 0 1 (2) 0.481
Gestational age at admission (w) 25.7 (23.2; 28.1) 29.7 (25.9; 31.6) 0.001
Gestational age at vaginal sampling (w) 25.7 (23.3; 28.3) 29.9 (26.4; 31.7) 0.001
CRP (mg/dL) at admission 2.1 (0.9; 4.0) 0.5 (0.3; 1.1) <0.001
WBC count (×109) at admission 13580 (10730; 15295) 12280 (9010; 15200) 0.268
Amniotic fluid IL-6 (ng/mL) 51.6 (23.4; 187.3) 1.2 (0.7; 2.7) <0.001
Cervical length (mm) at admission 8.0 (0; 16.5) 11.0 (6.0; 22.0) 0.128
Antibiotics prior to vaginal sampling 10 (48) 9 (21) 0.028
Latency from antibiotic administration to vaginal sampling (d) 0.5 (0; 1) 0.5 (0; 2) 0.652
Steroids prior to vaginal sampling 9 (43) 32 (74) 0.013
Tocolysis during lung maturation 15 (71) 41 (95) 0.012
Cerclage prior to vaginal sampling 3 (14) 2 (5) 0.177
Latency from sampling to delivery (d) 4.0 (1.0; 12.5) 42.0 (19.0; 67.8) <0.001
Gestational age at delivery (w) 27.6 (25.6; 30.4) 36.8 (32.4; 38.4) <0.001
- Spontaneous delivery <28.0 w 11/15 (73) 0 <0.001
- Spontaneous delivery <32.0 w 19/20 (95) 8/32 (25) <0.001
- Spontaneous delivery <34.0 w 19 (90) 13/38 (34) <0.001
- Spontaneous delivery <37 w 20 (95) 19/38 (50) <0.001
Clinical chorioamnionitis at the onset of labor 6 (29) 1/38 (3) 0.003
Table 1. Maternal characteristics and pregnancy outcomes.
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Vaginal microbiota composition in women with IAI. Differences in the relative abundance of bacteria 
have been observed at family (Fig. 1B) and genus level (Fig. 1C). A higher relative abundance of Lactobacillus 
genus was observed in women with No-MIAC/Non-IAI and a higher microbial-diversity in women with IAI.
Using the LEfSe test at the genus level, we found enrichment of Ureaplasma (LDA 4.34 score, p = 0.008), 
Peptoniphilus (LDA 3.73 score, p = 0.050), Gardnerella (LDA 4.56 score, p = 0.039) and Haemophilus (LDA 
4.37 score, p = 0.077) in women with IAI and of Lactobacillus (LDA 5.09, p = 0.038) in women with No-MIAC/
Non-IAI (Fig. 2).
Similar observation on Lactobacillus genus abundance was observed by both methodologies, sequencing as 
relative abundance (p = 0.015) and specific qPCR as total load (p = 0.043). We found a depletion of Lactobacillus 
spp. load in women with IAI but not of Lactobacilllus iners (Fig. 3).
Correlation between microorganisms found in the AF and vaginal microbiota. Correlation 
between microorganisms isolated in the AF and vaginal microbiota was performed using Spearman correlation 
analysis (Fig. 4). Most of the microorganisms isolated in the AF were also found in the vaginal microbiota except 
for Roseomonas mucosa, Rhodococcus spp. and Capnocytophaga sputigena.
Figure 1. (A) Boxplot showing alpha diversity metrics of Shannon index (microbial-diversity) and Chao1 
(richness) in women with or without IAI. (B) Comparison and relative abundance of microbial taxa at family 
level in women with or without IAI. (C) Comparison and relative abundance of microbial taxa at genus level in 
women with or without IAI.
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Association between IAI and vaginal microbiota. We observed a significant inverse association 
between IL-6 concentrations and load of Lactobacillus spp. (β −0.253, t −2.76, p 0.008).
No association was found between microbial-diversity and IL-6 (β 0.334, t 1.77), p 0.081).
Vaginal microbiota and infectious outcomes. Microbial-diversity (Shannon index) was found to be a 
risk factor (OR 4.1 95% CI 1.18–14.09) for the subsequent occurrence of clinical chorioamnionitis. To the con-
trary, Lactobacillus spp. load had a protective role (OR of 0.5 95% CI 0.29–0.88).
Vaginal microbiota, gestational age at delivery and spontaneous preterm birth. Lactobacillus 
spp. load depletion was significantly associated with an early gestational age at delivery (β 0.359, t (57) 2.742, p 
0.008) and a short latency from vaginal sampling to delivery (β 0.29, 2.151 (57), p 0.036). To the contrary, in the 
binary logistic regression model, the Lactobacillus spp. load was found to be a protective factor for the occurrence 
of spontaneous delivery within 7 days (OR of 0.34 95% CI 0.17–0.68) and <34 weeks (OR 0.55 95% CI 0.31–0.98). 
The ROC curve showed an area under the curve of load of Lactobacillus spp. for predicting sPTB <34 weeks of 
0.69, with a 95% confidence interval of 0.55–0.83. No associations between Lactobacillus iners and the different 
outcomes evaluated were observed.
Figure 2. LEfSe test at genus level.
Figure 3. Lactobacillus spp. (A) and L. iners (B) relative abundance (%) by sequencing and total load by 
specific quantitative PCR.
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Discussion
Our study showed that total Lactobacillus genus load is inversely associated with IAI. In agreement with previous 
studies13–15, Lactobacillus spp. depletion is associated with early gestational age at delivery and short latency from 
vaginal sampling to delivery. Furthermore, both microbial-diversity and Lactobacillus spp. depletion are associ-
ated with subsequent clinical chorioamnionitis.
It is well known that the prevalence of IAI is of up to 40% when symptoms of PTL occur <28 weeks2–4. For cli-
nicians, the importance to identify this inflammatory condition is to select the group of women with the highest 
risk of delivery within the following days16.
Despite the clinical relevance of IAI, amniocentesis is still required for achieving diagnosis at present. This has 
become an incentive to explore the intra-amniotic environment through alternative and non-invasive strategies 
such as the characterization of the vaginal or the cervical fluid microbiota composition.
Lactobacillus has been proposed as one of the vaginal microbes that modulate maternal response to infection 
and down-regulates inflammation7,8,10 inhibiting induction of pro-inflammatory cytokines17. Concerning preg-
nancy, there is increasing evidence showing that non-Lactobacillus bacteria generally associated with bacterial 
vaginosis are highly correlated with the expression of pro-inflammatory cytokines, which may play a role in the 
onset of labor in women with sPTB10,18. Moreover, there are some trials suggesting a reduction in the recurrence 
of bacterial vaginosis in women treated with Lactobacillus19.
What is of note in our paper is that it characterizes vaginal microbiota composition in women with PTL who 
had undergone amniocentesis to rule out IAI. In this regard, Hitti et al.11 did observe a high expression of vagi-
nal cytokines, an abnormal vaginal Gram stain, absence of hydrogen peroxide-producing Lactobacillus and the 
presence of anaerobic microorganisms in the vaginal cultures of women with MIAC and IAI. In line with these 
authors, we also found a depletion of Lactobacillus spp. in women with IAI although we did not find differences 
in microbial-diversity. What differentiates our findings from those observed by Hitti et al.11 was the methodology 
used to characterize vaginal microbiota composition. The performance of molecular techniques detecting specific 
bacterial fragments (such as PCR targeted to Lactobacillus spp.) and non-specific bacterial fragments (such as 16S 
ribosomal RNA gene amplicon sequencing) improves the identification of the composition of vaginal microbiota 
in comparison to the standard culture used by Hitti et al.11.
In PPROM without labor, the only previous study describing cervical microbiota in women with IAI was by 
Kacerovsky et al.12. These authors observed a significant depletion of Lactobacillus spp. and a high abundance of 
bacteria typically associated with bacterial vaginosis in women exposed to MIAC and/or IAI. In contrast, women 
with No-MIAC/Non-IAI were characterized by an abundance of Lactobacillus crispatus suggesting a protective 
role of these bacteria against the exposition to MIAC and/or IAI. We found an inverse association between bac-
terial load of Lactobacillus spp. and exposition to IAI. Thus, similar to Kacerovsky et al.12, we observed a high 
microbial-diversity in women with IAI with an enrichment of bacteria related to bacterial vaginosis including 
Ureaplasma, Prevotella, Haemophilus and Peptoniphilus. Interestingly, the presence of IAI was related to a deple-
tion of Lactobacillus spp. load.
In line with other authors13–15, we also observed an inverse association between total Lactobacillus genus load 
and gestational age at delivery. However, unlike some authors such as Kindinger et al.13 and Petricevic et al.14, we 
did not observe an association between Lactobacillus iners and the risk of sPTB.
In women with PPROM, Brown et al.20 did observe an association between vaginal dysbiosis and the occur-
rence of histological chorioamnionitis and funisitis but Jayaprakas et al.21 did not. Unfortunately, we were not able 
to accurately evaluate the association between vaginal microbiota and histological chorioamnionitis or funisitis. 
However, we found microbial-diversity to be a risk factor (OR 4.07 95% CI 1.2–14.1) and Lactobacillus spp., a 
protective bacteria (OR of 0.5 95% CI 0.29–0.89) for the subsequent occurrence of clinical chorioamnionitis.
One of the main strengths of our study was the well-characterized infectious/inflammatory phenotype of our 
unique cohort that routinely performs amniocentesis to identify IAI as part of clinical management in women 
Figure 4. Spearman correlation analysis between amniotic fluid and vaginal microbiota.
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with PTL. Concerning this, there is emerging data emphasizing the importance to initiate antenatal antibiotic 
treatment early in the group of women with MIAC. Thus, Yoon et al.22 have recently reported that eradication of 
MIAC and IAI was possible after broad-spectrum antibiotic treatment in a substantial number of women with 
PTL. This emphasizes the importance of performing amniocentesis for this indication in women with PTL with 
early onset of symptoms. Another strength of this study was that we characterized Lactobacillus spp. by both 16S 
ribosomal RNA gene amplicon sequencing and specific quantitative PCR.
Although one of the limitations was the high rate of antibiotics administered in the entire study group 
(approximately 30% women were treated with antibiotics prior to vaginal sampling), we took into consideration 
this variable in our regression models. Finally, we acknowledge we did not characterize AF microbiota compo-
sition by 16S ribosomal RNA gene amplicon sequencing. However, to identify microorganisms in the AF, we 
performed not only specific culture media but also Sanger sequencing of the 16S ribosomal RNA gene.
From a clinical perspective, directions for future research should evaluate in larger cohort of women with 
PTL, the diagnostic performance of vaginal bacterial load of Lactobacillus spp. as a non-invasive marker of the 
intra-uterine environment.
In conclusion, we observed a reduced Lactobacillus load in women exposed to IAI, in those with an early 
gestational age at delivery or a short latency from vaginal sampling to delivery and found microbial-diversity and 
Lactobacillus spp. depletion to be associated with subsequent clinical chorioamnionitis.
Methods
Study design. From an observational cohort study (2008–2016) performed in women with PTL <34 weeks 
who had undergone amniocentesis to rule out IAI and with vaginal fluid collected, we selected 69 consecutive 
women. These women were admitted to the Department of Maternal-fetal Medicine at the Hospital Clinic, 
Barcelona, Spain.
Women with clinical signs of chorioamnionitis at admission, multiple gestation, PPROM, women who did 
not consent to participate in the study and those in whom amniocentesis was not technically possible were not 
eligible for this study.
Patient selection and sampling procedures were performed in accordance with the Declaration of Helsinki 
and applicable local regulatory requirements after approval from the Ethics Committee of the Hospital Clinic of 
Barcelona (HCB/2010/5811; HCB/2017/0821). Written informed consents were obtained from all subjects.
Clinical definitions and management. Gestational age was established according to the first-trimester 
ultrasound scan.
The definition of PTL and antenatal management has been reported previously23,24. Briefly, the standard ante-
natal management of women with PTL included lung maturation with a complete course of antenatal steroids 
(betamethasone 12-mg intramuscular injection with two doses given 24 hours apart) at between 24.0 to 34.6 
weeks. Tocolysis (nifedipine or atosiban) was considered to complete maturation with steroids in the absence of 
clinical chorioamnionitis, placenta abruption or non-reassuring fetal status. In women with a diagnosis of MIAC 
tocolysis was discontinued. Regarding antibiotic treatment, women with AF glucose levels <5 mg/dL and/or 
with microorganisms determined by Gram staining and/or positive cultures were treated with parenteral antibi-
otics during 10 days according to the antibiogram of the microorganism isolated. Prophylactic antibiotics were 
also considered (endovenous ampicillin 1 g/6 h, endovenous gentamycin 80 mg/8 h and oral azithromycin 1 g) in 
women with advanced cervical dilatation (Bishop index ≥6) until AF culture results were obtained. In case of 
negative cultures, prophylactic antibiotic treatment was discontinued. From 2011 onwards, magnesium sulfate 
was administered for fetal neuroprotection between 24.0 and 32.0 weeks if imminent labor was suspected.
Clinical chorioamnionitis was defined based on the criteria of Gibbs et al.25.
Amniotic fluid and vaginal fluid collection. Amniotic fluid (AF) was obtained by transabdominal amni-
ocentesis at admission and kept at 4 °C until processing.
Vaginal fluid was collected using swabs (Cytobrush Plus GT; Medscan Medical AB) from the posterior vagi-
nal fornix immediately after amniocentesis or within 24 h. Each Cytobrush was submerged in 1.0 mL of sodium 
chloride (NaCl) (9 mg/mL) and kept at 4 °C until processing. Vaginal fluid was centrifuged at 3000 g at 4 °C for 
10 minutes and pellet was stored at −80 °C until analysis.
Diagnosis of IAI and MIAC. In all samples, we measured the level of IL-6 in AF by enzyme-linked immu-
noassay (ELISA) (Biosource; Invitrogen, Carlsbad, CA), previously centrifuged at 4,000 rpm for 10 minutes at 
4 °C and stored at −80 °C. The minimum detectable level of IL-6 was 0.2 ng/mL. We defined IAI according to 
the receiver operating characteristic curve analysis of IL-6 (expressed in a log scale) previously employed by our 
group4,23,26 and similar to that reported by Romero et al.27.
MIAC was defined by the presence of a positive AF culture for bacteria (chocolate agar for aerobes, Schaedler 
agar for anaerobes and thioglycollate broth) and for Ureaplasma spp. or Mycoplasma hominis (Mycoplasma IST 
2, bioMérieux). All samples were further analyzed by specific polymerase chain reaction (PCR) amplification of 
the 16S ribosomal RNA gene using the primers: 5′- AGA GTT TGA TCC TGG CTC AG - 3′ and 5′- GGA CTA 
CCA GGG TAT CTA AT - 3′ followed by Sanger sequencing in the Department of Microbiology. Sequences were 
identified using the Blast algorithm in the NCBI database, with minimum 98% sequence identity.
DNA extraction, 16s ribosomal RNA gene amplification and sequencing. DNA extraction from 
the vaginal swabs was performed using the Purelink Microbiome DNA Purification Kit (Invitrogen) according 
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to the manufacturer’s instructions. DNA concentrations were measured using a Qubit® 2.0 Fluorometer (Life 
Technology, Carlsbad, CA, USA).
The 16S ribosomal RNA sequencing library was constructed following the 16S rDNA gene Metagenomic 
Sequencing Library Preparation Illumina protocol, targeting the V3 and V4 hypervariable regions. After 16S 
rDNA gene amplification, the mutiplexing step was performed using the Nextera XT Index Kit (Illumina, Inc.). 
The libraries were sequenced using a 2 × 300pb paired-end run (MiSeq Reagent kit v3 (Illumina, Inc.)) on a 
MiSeq Sequencer according to the manufacturer’s instructions (Illumina, Inc.).
Data and statistical analysis. Quality assessment was performed with the use of the prinseq-lite program28 
(min_length: 50; trim_qual_right: 30; trim_qual_type: mean; trim_qual_window: 20). Forward and reverse reads 
were joined using FLASH program29 applying default parameters.
Chimeric sequences were removed using the UCHIME program version 4.2. Open reference OTU picking was 
performed at 97% identity and were classified using the RDP algorithm30 in combination with the RDP database 
version 11.
Samples with less than 1,000 sequence reads were removed. Singletons and OTUs with a relative frequency 
<0.01% were also removed. A maximum of 3,000 taxa were included. Sequences classified as Cyanobacteria and/
or Chloroplasts were removed.
OTU tables were rarefied to 8,054 sequences per sample to avoid variations in sequencing depth. To assess 
alpha-diversity, richness (Chao1 and ACE indexes) and microbial-diversity (Shannon and Simpson indexes) were 
computed at genus and OTU levels. Beta-diversity using weighted and unweighted UNIFRAC (phylogenetic dis-
tance) and Bray Curtis distance (non-phylogenetic) were used as input for ordination analysis using non-metric 
multidimensional scaling (NMDS). The Calypso software version 8.24 (http://cgenome.net/calypso/) was used for 
data mining and multivariate analysis. Linear discriminant analysis effect size (LEfSe) was used to detect unique 
biomarkers (linear discriminant analysis (LDA) score >3.0) in relative abundance of bacterial taxonomy31.
Bacterial load of Lactobacillus spp. by quantitative PCR. Quantitative PCR (qPCR) amplification 
and detection were performed with specific primers targeted to the 16S region for Lactobacillus spp.32 and a 
specific toxin from Lactobacillus iners33 in each vaginal sample. Each reaction mixture of 20 μl was composed of 
KAPA Sybr Fast qPCR Kit (KAPA Biosistems), 0.4 μl of each primer (10 μM concentration) and 1 μl of template 
DNA in a Light Cycler 480 Real-Time PCR System (Roche Technologies). All amplifications were performed in 
duplicates. The bacterial concentration in each sample was calculated by comparison with the Ct values obtained 
from a standard curve and also, a negative control was included in each reaction plate. These were generated using 
serial 10-fold dilutions of gene.
Data was normalized for total DNA concentrations (ng/μL) and presented in a logarithmic scale (log number 
copies gene/ng total DNA).
Statistical analysis. Statistical analysis of demographic data and pregnancy outcomes were performed 
using the SPSS 20.0 for MAC OS (IBM Corporation, USA). The normality of the data was tested using the 
Kolmogorov-Smirnov normality test and the Shapiro-Wilk test. Continuous variables were presented as median 
(25th, 75th percentile). Categorical variables were presented as numbers or percentages (%). The association of 
vaginal microbial-diversity and bacterial load of Lactobacillus spp. (expressed as log n copies gene/ng total DNA) 
to predict different outcomes was evaluated using linear and logistic regression analysis. Regression models took 
into consideration whether antibiotic was administered prior vaginal sampling. Receiver operating characteristics 
(ROC) curve analysis was employed to display the relationship between sensitivity and the false-positive rate (1 – 
specificity) of bacterial load of Lactobacillus spp. for diagnosing sPTB <34 weeks.
All differences were considered statistically significant with a p < 0.05 with two-sided alternative hypotheses.
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